BMRN FY 2019 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.7B+14.3% YoY

Gross Profit

$1.3B78.9% margin

Operating Income

-$100M-5.9% margin

Net Income

-$24M-1.4% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

$48M

Free Cash Flow

-$97M

Stock-Based Comp.

$160M

Balance Sheet

Total Assets

$4.7B

Total Liabilities

$1.6B

Stockholders' Equity

$3.1B

Cash & Equivalents

$437M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.5B	+14.3%
Gross Profit	$1.3B	$1.2B	+14.3%
Operating Income	-$100M	-$124M	+18.7%
Net Income	-$24M	-$77M	+69.1%